Single Technologies secures €12.5 million in EU funding to scale 3D sequencing and power biological AI

Gustav Ceder, 8 July 2025

Stockholm, July 2025 – Single Technologies has secured €12.5 million in blended funding from the European Innovation Council (EIC) Accelerator, one of Europe’s most competitive and prestigious funding programs for breakthrough technology startups.

The funding consists of a €2.5 million non-dilutive grant and a €10 million direct equity investment from the EIC Fund, Europe’s largest investor in deep tech. Out of 150 companies that reached the final evaluation round, only 40 were selected for funding in this cycle, underscoring the highly selective and strategic nature of the program.

“This is not only a validation of our technology—it’s a strategic inflection point for our company,” said Johan Strömqvist, CEO and founder of Single Technologies, in a statement to GenomeWeb. “With the support of the EU and EIC, we’re now ready to scale globally, expand production capacity, grow the team, and accelerate commercialization of our platform.”

Building the infrastructure for biological AI

Single Technologies is developing Theta™, a 3D spatial sequencing platform that reads biological information directly in tissue and cells, in three dimensions, with molecular precision. Unlike traditional 2D flow cell-based sequencing methods, Theta™ enables high-throughput capture of spatial omics data at a previously impossible scale.

The platform is also designed to make whole genome sequencing available at an unprecedented price point—scaling down costs to as little as $10 per genome, unlocking new possibilities for population-scale genomics, AI-driven biology, personalized medicine and longevity.

Strömqvist commented in an article by Life Science Sweden:

“For years, we have built and refined our truly transformative 3D sequencing platform, enabling massively parallel omics data at an unprecedented scale. Now, as biology and AI are converging, we are proud to support this intersection with large-scale, affordable, and uniquely rich data.”

The company sees its platform as foundational to the next wave of AI-driven biology, enabling the type of data needed to train large biological models—much like Nvidia’s graphics processing unit became essential for powering generative AI.

NyTeknik noted in an article that the company’s ambition is nothing less than to become the technical infrastructure for biological AI. The article emphasized Single’s potential in enabling breakthroughs in precision medicine, cancer research, and virtual cell modeling, referencing ongoing work at Google DeepMind to build digital replicas of human cells.

Prestigious and strategic European backing

The EIC Accelerator is the EU’s flagship funding instrument for high-impact tech startups. It combines non-dilutive grants with strategic equity investments through the EIC Fund, which operates as a long-term, risk-tolerant investor alongside private capital. As Life Science Sweden reports, the EIC support also includes access to expert networks, large corporates, and potential co-investors, making it a key catalyst for scaling.

Single Technologies was one of only two Swedish biotech firms selected in this round, alongside Pixelgen Technologies, another Stockholm-based company that received €12.5 million to advance its 3D protein interaction mapping kit.

The EIC Fund has quickly grown into one of the largest and most active deep tech investors in Europe. GenomeWeb reported that approximately €229 million in total funding was distributed in this round, covering grant and equity components. The fund’s investment decisions follow rigorous due diligence and are designed to support companies with global growth potential.

A new chapter for Single Technologies

The EIC funding will support Single Technologies’ efforts to scale up production, accelerate hiring, and advance international commercialization. As the field of biology moves toward AI-powered discovery, the need for rich, spatially resolved omics data is growing exponentially—and Single Technologies is positioning itself as the backbone infrastructure for this transformation.

Read more:

• European Innovation Council — “From health to space: 40 start-ups secure EIC support in latest round of the EIC Accelerator”

  
  

• GenomeWeb — Life Science Firms Receive €25M-Plus in Funding From European Innovation Council (already in English)

  
  

• NyTeknik — “Swedish Single Technologies Receives SEK 140 Million – ‘The Nvidia for Biological AI’”

  
  

• Life Science Sweden — “Funding Windfall for Two Swedish Biotech Companies – Selected by the EU Innovation Council”

  
  

• Swedish Tech Weekly — “Newsletter #314”